In the present study, we demonstrated that NAFLD and, furtherly, the more severe NASH, lead to brain dysfunction characterized by a modulation of BA receptors FXR and TGR5. Here, GPBAR1 is linked to metabolic dysfunction-associated steatotic liver disease.